Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.

Literature DB >> 27957152

Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic cardiovascular disease that predisposes individuals to the development of arrhythmias. The most common sustained arrhythmia is atrial fibrillation (AF). Compared with the general population, patients with HCM are more prone to the development of AF. To avoid embolic complications and the clinical deterioration caused by the development of AF in HCM, identifying patients with a tendency toward AF might affect the management of HCM. In this review, we evaluated the predictors of AF development in patients with HCM.

Entities: Disease Species

Keywords: Atrial Fibrillation; Hypertrophic Cardiomyopathy; Left Atrium; Predictors

Year: 2015 PMID： 27957152 PMCID： PMC5135220 DOI： 10.4022/jafib.1200

Source DB: PubMed Journal: J Atr Fibrillation ISSN： 1941-6911

39 in total

1. Interatrial dyssynchrony on tissue Doppler imaging predicts progression to chronic atrial fibrillation in patients with non-valvular paroxysmal atrial fibrillation.

Authors: K Sakabe; N Fukuda; Y Fukuda; S Morishita; H Shinohara; Y Tamura
Journal: Heart Date: 2009-03-05 Impact factor: 5.994

2. Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy?

Authors: K Yamaji; S Fujimoto; C Yutani; Y Ikeda; R Mizuno; T Hashimoto; S Nakamura
Journal: Cardiovasc Pathol Date: 2001 Nov-Dec Impact factor: 2.185

Review 3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094

4. [Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy].

Authors: Yu N Belenkov; E V Privalova; V Yu Kaplunova; D V Stambol'skiĭ; A A Fomin
Journal: Kardiologiia Date: 2010 Impact factor: 0.395

5. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors: A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal: Heart Date: 2000-11 Impact factor: 5.994

6. Determinant of left atrial dilation in patients with hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study.

Authors: Fabrice Bauer; Takahiro Shiota; Richard D White; Harry M Lever; Jian Xin Qin; Jeannie Drinko; Maureen Martin; Hiroyuki Tsujino; Marta Sitges; Yong Jin Kim; James D Thomas
Journal: J Am Soc Echocardiogr Date: 2004-09 Impact factor: 5.251

7. Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors: Tomoko Tani; Kazuaki Tanabe; Miwa Ono; Kazuto Yamaguchi; Midori Okada; Toshiaki Sumida; Toshiko Konda; Yoko Fujii; Junichi Kawai; Toshikazu Yagi; Masatake Sato; Motoaki Ibuki; Minako Katayama; Koichi Tamita; Kenji Yamabe; Atsushi Yamamuro; Kunihiko Nagai; Kenichi Shiratori; Shigefumi Morioka
Journal: J Am Soc Echocardiogr Date: 2004-06 Impact factor: 5.251

8. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

Authors: Barry J Maron; Iacopo Olivotto; Pietro Bellone; Maria Rosa Conte; Franco Cecchi; Björn P Flygenring; Susan A Casey; Thomas E Gohman; Sergio Bongioanni; Paolo Spirito
Journal: J Am Coll Cardiol Date: 2002-01-16 Impact factor: 24.094

9. Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study.

Authors: Shunichi Nakamura; Hitoshi Takano; Junya Matsuda; Daigo Chinen; Mitsunobu Kitamura; Koji Murai; Kuniya Asai; Masahiro Yasutake; Morimasa Takayama; Wataru Shimizu
Journal: BMJ Open Date: 2014-09-17 Impact factor: 2.692

10. An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography.

Authors: Ashraf M Anwar; Osama I I Soliman; Attila Nemes; Marcel L Geleijnse; Folkert J ten Cate
Journal: Int J Cardiovasc Imaging Date: 2007-05-31 Impact factor: 2.357

2 in total

1. Role of fibroblast growth factor-23 (FGF-23) in the prediction of postoperative atrial fibrillation after coronary artery bypass surgery.

Authors: Kartik Pandurang Jadhav; Praveen Gopalakrishna Pai; Indu Nair; Sajitha Krishnan; Praveen Kerala Varma
Journal: Indian J Thorac Cardiovasc Surg Date: 2022-03-10

Review 2. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.

Authors: Lohit Garg; Manasvi Gupta; Syed Rafay Ali Sabzwari; Sahil Agrawal; Manyoo Agarwal; Talha Nazir; Jeffrey Gordon; Babak Bozorgnia; Matthew W Martinez
Journal: Heart Fail Rev Date: 2019-03 Impact factor: 4.214

2 in total